Developer docs
API playgroundTry for free, no card

Search company profiles

Arthrosurface

Full company profile

uuid0006gwd

Namestring
Arthrosurface
Legal namestring
Arthrosurface, Inc.
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Arthrosurface is a privately held orthopedic medical device company founded in 2002 and headquartered in West Bridgewater, Massachusetts, with a stated 101–250 employee footprint. The company develops and commercializes motion-preserving joint restoration implants spanning the shoulder, wrist, thumb, knee, foot, and ankle. Its core technology is the HemiCAP (Contoured Articular Prosthesis) platform, which uses 3D joint mapping to match more than 150 patient-specific implant curvatures to damaged articular surfaces, paired via Morse taper lock fixation that enables inlay placement preserving native bone and soft tissue. The portfolio extends the same motion-preserving design philosophy across systems including OVO and OVOMotion shoulder arthroplasty, RevoMotion reverse shoulder, WristMotion hemiarthroplasty and total wrist arthroplasty, PF Wave and UniCAP knee resurfacing, WaveKahuna patellofemoral knee, SpeedSpiral thumb CMC, and ToeMotion total toe replacement, supported by allograft and fixation adjuncts such as CheckMATE, ToeMATE, BOSS, and SpiralUP TCL.

The business operates a hybrid go-to-market: a US direct field sales force organized across Central, East, and West territories selling implants and instrumentation directly to hospitals and ambulatory surgery centers, complemented by an international distributor network covering more than 25 countries. Revenue is generated through hardware sales of sterile-packaged implants and reusable/loned surgical instruments, with surgeon adoption supported by cadaveric training, peer-reviewed clinical evidence (200+ publications and book chapters), and an installed base reported at 5,000+ surgeons globally and 2,000+ US facilities, including 34 of the top 50 orthopedic hospitals ranked by US News & World Report. Since founding, Arthrosurface reports over 100,000 patients treated.

The company was originally spun out of Primo Medical Group's machine shop, accumulated approximately $18.5M across six disclosed funding rounds between 2002 and 2008 led by Boston Millennia Partners, was subsequently owned by Anika Therapeutics, and was reacquired in October 2024 by Primo Medical Group's executive team, returning it to private operating ownership.

Short descriptiontext

Arthrosurface is a privately held orthopedic medical device company that develops motion-preserving joint resurfacing implants (shoulder, wrist, thumb, knee, foot, ankle) for orthopedic surgeons, hospitals, and ambulatory surgery centers across the US and 25+ international markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersFranklin, United States
HQ citystring
Franklin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic joint resurfacing, minimally invasive implants, joint preservation devices, extremity surgical implants, hemiarthroplasty systems
Industry3 codes
1Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle)
CodeHLAHAEAAPrimaryYes
2Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryNo
33D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Joint Resurfacing Implants
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales - Implants and Instruments
TypeHardware Sales
Description

Arthrosurface generates revenue through the sale of orthopedic implants and surgical instruments to healthcare providers, hospitals, and ambulatory surgery centers. Products include joint resurfacing implants for knee, shoulder, wrist, foot/ankle, and toe applications, along with associated surgical instrumentation sets.

arthrosurface.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1WristMotion
Description

WristMotion Hemiarthroplasty Implant System and Total Wrist Arthroplasty System for wrist joint replacement

arthrosurface.com
+8 more records
Core offering1 text field

Arthrosurface designs, manufactures, and markets proprietary joint resurfacing implants (notably the HemiCAP system) used by orthopedic surgeons to treat focal cartilage and joint surface defects in the knee, shoulder, hip, ankle, wrist, and toe. The company focuses on joint-preserving alternatives to total joint replacement, enabling less invasive surgical procedures that conserve native bone and allow for future treatment options.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 100,000 patients treated since company founding in 2002
+3 more records
Product overview1 text field

Arthrosurface is a joint preservation technology company offering a comprehensive portfolio of motion-preserving implant systems across multiple anatomical regions. The product portfolio centers on the proprietary HemiCAP® platform technology—a cap and screw system with Morse taper lock fixation that resurfaces only the damaged area of a joint, similar to a dental filling. The offering spans shoulder systems (Shoulder HemiCAP®, OVO®, OVOMotion® with Inlay Glenoid, RevoMotion® Reverse Shoulder), upper extremity systems (WristMotion® Hemiarthroplasty and Total Wrist Arthroplasty, SpeedSpiral® Thumb CMC), knee systems (PF Wave®, WaveKahuna™, UniCAP®), and foot/ankle systems (HemiCAP® Toe, ToeMotion® Total Toe, CheckMATE® Fusion Plate, ToeMATE®, BOSS, SpiralUP TCL). Supporting products include the Glenojet® Allograft System for glenoid reconstruction. The portfolio comprises over 150 different surface implant curvatures designed to treat upper and lower extremity orthopedic conditions.

Product and service6 records
1HemiCAP Knee Resurfacing System
CategoryOrthopedic Joint Resurfacing Implants
2HemiCAP Shoulder Resurfacing System
CategoryOrthopedic Joint Resurfacing Implants
3HemiCAP Toe Resurfacing System (ToeMotion)
CategoryOrthopedic Joint Resurfacing Implants
4HemiCAP Ankle Resurfacing System
CategoryOrthopedic Joint Resurfacing Implants
5HemiCAP Wrist Resurfacing System
CategoryOrthopedic Joint Resurfacing Implants
6HemiCAP Hip Resurfacing System
CategoryOrthopedic Joint Resurfacing Implants
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Privately held leader in sports medicine and orthopedic soft-tissue repair, with growing extremities and joint preservation offerings. Competes with Arthrosurface in shoulder, foot/ankle, and minimally invasive joint procedures via a similarly surgeon-focused sales model.

TypeBroad incumbent
Description

Global medical device company with established orthopedic reconstruction and sports medicine businesses. Competes with Arthrosurface in shoulder and knee, and has invested in resurfacing and stemless implant technologies.

TypeBroad incumbent
Description

Orthopedic implant company specializing in shoulder, knee, and hip replacement. Directly competitive with Arthrosurface in stemless and anatomic shoulder arthroplasty and was acquired by TPG to accelerate growth in joint preservation.

TypeBroad incumbent
Description

J&J's orthopedic and neurosurgery arm offering total joint replacement and extremities solutions. Competes with Arthrosurface in shoulder arthroplasty and foot/ankle, with substantially larger IDN-level contracting leverage.

TypeEmerging player
Description

Patient-specific knee replacement technology company that, like Arthrosurface, emphasizes customized implants and motion preservation. Comparable in approach to patient-matched design rather than off-the-shelf total knee arthroplasty.

TypeBroad incumbent
Description

One of the largest global orthopedic device companies with broad joint replacement, sports medicine, and extremities portfolios. Competes with Arthrosurface across shoulder, knee, and foot/ankle, and has aggressively expanded into stemless and inlay shoulder resurfacing through acquisitions.

TypeBroad incumbent
Description

Medical technology company with a surgical orthopedic implant business that competes in shoulder, hip, and extremities. Overlapping customer base with Arthrosurface among orthopedic surgeons and ASCs.

TypeBroad incumbent
Description

Global orthopedic leader with comprehensive joint reconstruction, sports medicine, and extremities franchises. Directly competes with Arthrosurface in shoulder, knee, and wrist, with established sales coverage in the same 2,000+ US facilities Arthrosurface serves.

TypeDirect peer
Description

Previous owner of Arthrosurface until the October 2024 divestiture. Operates in adjacent orthopedic viscosupplementation and regenerative cartilage repair markets; Arthrosurface's product line was historically integrated into Anika's joint preservation franchise.

TypeEmerging player
Description

Smaller orthopedic resurfacing competitor with partial joint restoration implants. Comparable niche positioning to Arthrosurface as a focused resurfacing innovator rather than full-line joint replacement vendor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arthrosurface

Orthopedic Joint Resurfacing Implantsarthrosurface.com

Arthrosurface is a privately held orthopedic medical device company that develops motion-preserving joint resurfacing implants (shoulder, wrist, thumb, knee, foot, ankle) for orthopedic surgeons, hospitals, and ambulatory surgery centers across the US and 25+ international markets.

What Arthrosurface does

Arthrosurface is a privately held orthopedic medical device company founded in 2002 and headquartered in West Bridgewater, Massachusetts, with a stated 101–250 employee footprint. The company develops and commercializes motion-preserving joint restoration implants spanning the shoulder, wrist, thumb, knee, foot, and ankle. Its core technology is the HemiCAP (Contoured Articular Prosthesis) platform, which uses 3D joint mapping to match more than 150 patient-specific implant curvatures to damaged articular surfaces, paired via Morse taper lock fixation that enables inlay placement preserving native bone and soft tissue. The portfolio extends the same motion-preserving design philosophy across systems including OVO and OVOMotion shoulder arthroplasty, RevoMotion reverse shoulder, WristMotion hemiarthroplasty and total wrist arthroplasty, PF Wave and UniCAP knee resurfacing, WaveKahuna patellofemoral knee, SpeedSpiral thumb CMC, and ToeMotion total toe replacement, supported by allograft and fixation adjuncts such as CheckMATE, ToeMATE, BOSS, and SpiralUP TCL.

The business operates a hybrid go-to-market: a US direct field sales force organized across Central, East, and West territories selling implants and instrumentation directly to hospitals and ambulatory surgery centers, complemented by an international distributor network covering more than 25 countries. Revenue is generated through hardware sales of sterile-packaged implants and reusable/loned surgical instruments, with surgeon adoption supported by cadaveric training, peer-reviewed clinical evidence (200+ publications and book chapters), and an installed base reported at 5,000+ surgeons globally and 2,000+ US facilities, including 34 of the top 50 orthopedic hospitals ranked by US News & World Report. Since founding, Arthrosurface reports over 100,000 patients treated.

The company was originally spun out of Primo Medical Group's machine shop, accumulated approximately $18.5M across six disclosed funding rounds between 2002 and 2008 led by Boston Millennia Partners, was subsequently owned by Anika Therapeutics, and was reacquired in October 2024 by Primo Medical Group's executive team, returning it to private operating ownership.

Arthrosurface firmographics

Firmographics
Name
Arthrosurface
Legal name
Arthrosurface, Inc.
Website
https://arthrosurface.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
101–250 employees
Short description
Arthrosurface is a privately held orthopedic medical device company that develops motion-preserving joint resurfacing implants (shoulder, wrist, thumb, knee, foot, ankle) for orthopedic surgeons, hospitals, and ambulatory surgery centers across the US and 25+ international markets.
Ownership category
akta.pro rank

Arthrosurface industry classification

Industry
Product category
Orthopedic Joint Resurfacing Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)
akta.pro secondary industries
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

  • Orthopedic joint resurfacing
  • Minimally invasive implants
  • Joint preservation devices
  • Extremity surgical implants
  • Hemiarthroplasty systems

Where Arthrosurface is headquartered

Location

Headquarters

HQ city
Franklin
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arthrosurface business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales - Implants and Instruments: Arthrosurface generates revenue through the sale of orthopedic implants and surgical instruments to healthcare providers, hospitals, and ambulatory surgery centers. Products include joint resurfacing implants for knee, shoulder, wrist, foot/ankle, and toe applications, along with associated surgical instrumentation sets.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

Arthrosurface product offering

Product offering

Core offering

Arthrosurface designs, manufactures, and markets proprietary joint resurfacing implants (notably the HemiCAP system) used by orthopedic surgeons to treat focal cartilage and joint surface defects in the knee, shoulder, hip, ankle, wrist, and toe. The company focuses on joint-preserving alternatives to total joint replacement, enabling less invasive surgical procedures that conserve native bone and allow for future treatment options.

Product overview

Arthrosurface is a joint preservation technology company offering a comprehensive portfolio of motion-preserving implant systems across multiple anatomical regions. The product portfolio centers on the proprietary HemiCAP® platform technology—a cap and screw system with Morse taper lock fixation that resurfaces only the damaged area of a joint, similar to a dental filling. The offering spans shoulder systems (Shoulder HemiCAP®, OVO®, OVOMotion® with Inlay Glenoid, RevoMotion® Reverse Shoulder), upper extremity systems (WristMotion® Hemiarthroplasty and Total Wrist Arthroplasty, SpeedSpiral® Thumb CMC), knee systems (PF Wave®, WaveKahuna™, UniCAP®), and foot/ankle systems (HemiCAP® Toe, ToeMotion® Total Toe, CheckMATE® Fusion Plate, ToeMATE®, BOSS, SpiralUP TCL). Supporting products include the Glenojet® Allograft System for glenoid reconstruction. The portfolio comprises over 150 different surface implant curvatures designed to treat upper and lower extremity orthopedic conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • WristMotion: WristMotion Hemiarthroplasty Implant System and Total Wrist Arthroplasty System for wrist joint replacement
  • HemiCAP
  • OVO/OVOMotion
  • RevoMotion
  • ToeMotion
  • SpeedSpiral
  • ToeMATE
  • CheckMATE
  • Glenojet

Products and services

  • HemiCAP Knee Resurfacing System
  • HemiCAP Shoulder Resurfacing System
  • HemiCAP Toe Resurfacing System (ToeMotion)
  • HemiCAP Ankle Resurfacing System
  • HemiCAP Wrist Resurfacing System
  • HemiCAP Hip Resurfacing System

Quantifiable outcome

  • Over 100,000 patients treated since company founding in 2002
  • +3 more outcomes

Companies that use Arthrosurface

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles1 record

Arthrosurface technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Arthrosurface partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Arthrosurface competitors and assessment

Company assessment

Broad incumbents

  • Arthrex: Privately held leader in sports medicine and orthopedic soft-tissue repair, with growing extremities and joint preservation offerings. Competes with Arthrosurface in shoulder, foot/ankle, and minimally invasive joint procedures via a similarly surgeon-focused sales model.
  • Smith+Nephew: Global medical device company with established orthopedic reconstruction and sports medicine businesses. Competes with Arthrosurface in shoulder and knee, and has invested in resurfacing and stemless implant technologies.
  • Exactech: Orthopedic implant company specializing in shoulder, knee, and hip replacement. Directly competitive with Arthrosurface in stemless and anatomic shoulder arthroplasty and was acquired by TPG to accelerate growth in joint preservation.
  • DePuy Synthes (Johnson & Johnson MedTech): J&J's orthopedic and neurosurgery arm offering total joint replacement and extremities solutions. Competes with Arthrosurface in shoulder arthroplasty and foot/ankle, with substantially larger IDN-level contracting leverage.
  • Stryker: One of the largest global orthopedic device companies with broad joint replacement, sports medicine, and extremities portfolios. Competes with Arthrosurface across shoulder, knee, and foot/ankle, and has aggressively expanded into stemless and inlay shoulder resurfacing through acquisitions.
  • Enovis (DJO Surgical): Medical technology company with a surgical orthopedic implant business that competes in shoulder, hip, and extremities. Overlapping customer base with Arthrosurface among orthopedic surgeons and ASCs.
  • Zimmer Biomet: Global orthopedic leader with comprehensive joint reconstruction, sports medicine, and extremities franchises. Directly competes with Arthrosurface in shoulder, knee, and wrist, with established sales coverage in the same 2,000+ US facilities Arthrosurface serves.

Emerging players

  • ConforMIS: Patient-specific knee replacement technology company that, like Arthrosurface, emphasizes customized implants and motion preservation. Comparable in approach to patient-matched design rather than off-the-shelf total knee arthroplasty.
  • BioPoly: Smaller orthopedic resurfacing competitor with partial joint restoration implants. Comparable niche positioning to Arthrosurface as a focused resurfacing innovator rather than full-line joint replacement vendor.

Direct peers

  • Anika Therapeutics: Previous owner of Arthrosurface until the October 2024 divestiture. Operates in adjacent orthopedic viscosupplementation and regenerative cartilage repair markets; Arthrosurface's product line was historically integrated into Anika's joint preservation franchise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Arthrosurface social profiles

Digital presence

Arthrosurface financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arthrosurface leadership team

Management profile

Number of profiles

Profiles2 records

Arthrosurface funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arthrosurface M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arthrosurface

What does Arthrosurface do?

Arthrosurface designs, manufactures, and markets proprietary joint resurfacing implants (notably the HemiCAP system) used by orthopedic surgeons to treat focal cartilage and joint surface defects in the knee, shoulder, hip, ankle, wrist, and toe. The company focuses on joint-preserving alternatives to total joint replacement, enabling less invasive surgical procedures that conserve native bone and allow for future treatment options.

Is Arthrosurface a public or private company?

Arthrosurface is a private company. It is classified as corporate owned and is currently operating.

When was Arthrosurface founded?

Arthrosurface was founded in 2002. It employs 101 to 250 people.

Where is Arthrosurface based?

Arthrosurface is headquartered in Franklin, United States, in the North America region.

How does Arthrosurface make money?

One revenue line is on record: medical Device Sales - Implants and Instruments.

Who are Arthrosurface's main competitors?

Broad incumbents on record are Arthrex, Smith+Nephew, Exactech, DePuy Synthes (Johnson & Johnson MedTech), Stryker, Enovis (DJO Surgical) and Zimmer Biomet. Emerging players are ConforMIS and BioPoly. Anika Therapeutics is listed as a direct peer.

Does Arthrosurface have an API?

No public API is recorded for Arthrosurface.

What industry is Arthrosurface in?

Arthrosurface's product category is Orthopedic Joint Resurfacing Implants. Its primary akta.pro industry code is HLAHAEAA, Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle), with a secondary code of HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireArthrosurface Returns to it Roots Following Divestiture from Anika TherapeuticsPrimo Medical Group acquired Arthrosurface from Anika Therapeutics, with Phoenix Brio as the parent company. Arthrosurface's portfolio includes over 150 surface implant curvatures for knee, shoulder, wrist, and toe. The acquisition aims to restore Arthrosurface's leadership in orthopedic joint preservation.GlobeNewswireAnika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020Anika Therapeutics announced FDA clearance and planned Q3 2020 launch of six sports medicine and extremities products, including suture anchors and arthroplasty devices. The products address rotator cuff repairs, knee repairs, and arthritis damage, marking the first launches from its Parcus Medical and Arthrosurface acquisitions.PR NewswireClinical Study Shows Improved Clinical Outcomes, High Rate of Return to Activity for Patients with Arthrosurface OVO® with Inlay Glenoid Shoulder Arthroplasty SystemA clinical study published in the Journal of Shoulder and Elbow Surgery, conducted by Rush University Medical Center, found that patients treated with the Arthrosurface OVO® with Inlay Glenoid Shoulder Arthroplasty System experienced excellent clinical outcomes, including improved range of motion and no reoperations or radiographic loosening at an average follow-up of 40.4 months. The retrospective review of 27 shoulder procedures in 24 patients averaging 52.1 years of age showed an 85 percent return-to-activity rate, with most patients reporting the same or better physical fitness levels compared to before surgery. The OVO® system, developed by Arthrosurface, Inc., is designed as a primary solution for younger, active patients with glenohumeral osteoarthritis, a market segment projected to grow at 8.2 percent annually.GlobeNewswireAnika Therapeutics Closes Acquisition of ArthrosurfaceAnika Therapeutics completed its acquisition of Arthrosurface, paying approximately $60 million upfront and $40 million contingent on regulatory and commercial milestones. Arthrosurface's portfolio includes over 150 surface implant curvatures for orthopedic conditions. The deal expands Anika's joint preservation and restoration pipeline.PR NewswireClinical Study Demonstrates Equally Impressive Outcomes for Any Condition of Glenoid Using The Arthrosurface OVO® with Inlay Glenoid Total ShoulderA clinical study published in the Journal of Shoulder and Elbow Surgery reports that Arthrosurface's OVO® with Inlay Glenoid Shoulder Arthroplasty System provides significant pain relief and improved range of motion for patients with glenohumeral arthritis. The research, conducted at The Cleveland Clinic Foundation involving 29 patients, demonstrated consistent outcomes across different glenoid morphologies compared to traditional arthroplasty methods.PR NewswireArthrosurface Launches the SpeedSpiral™ CMC SystemArthrosurface, Inc. announced the launch of its SpeedSpiral™ CMC System, a new implant designed to treat thumb carpometacarpal (CMC) osteoarthritis by replacing arthritic bone with a load-bearing biologic implant. The device is the first of its kind and addresses a condition affecting up to 33 percent of women and 11 percent of men in their 50s and 60s, which causes 40 to 50 percent impairment to the upper extremity. CEO Steve Ek stated that the company has been searching for the most effective surgical treatment for this joint pathology for over a decade with guidance from their surgeon design team.PR NewswireArthrosurface Launches the Patellofemoral WaveKahuna Arthroplasty SystemArthrosurface, Inc. announced the launch of its Patellofemoral WaveKahuna Arthroplasty System, a next-generation implant for treating patellofemoral joint conditions including osteoarthritis, patellar dislocation, and failed previous surgery. The hybrid inlay-onlay implant restores patella and femoral trochlear groove anatomy while preserving native joint structure. Clinical data from a study of the original PF Wave implant showed high patient satisfaction, significant improvement in knee function and pain, and no radiographic progression of OA after five years.PR NewswireArthrosurface Launches the Stemless OVOMotion™ Shoulder Arthroplasty SystemArthrosurface, Inc. announced the official launch of its stemless OVOMotion™ Shoulder Arthroplasty System with Inlay Glenoid, which received FDA clearance in April 2018. The system is designed for patients with painful or severely disabled shoulder joints from arthritis, traumatic events, or AVN, offering increased glenoid exposure, minimal bone removal, and an aspherical head design. The device is now available for use in the United States and builds upon the clinical success of the existing OVO® arthroplasty device.PR NewswireArthrosurface Gains FDA Clearance of OVOMotion™ Shoulder Arthroplasty SystemArthrosurface received FDA 510(k) clearance on April 18, 2018, to market the OVOMotion Shoulder Arthroplasty System, a stemless total shoulder implant designed for patients with arthritis, traumatic injuries, or avascular necrosis. The system features an aspherical head design that replicates patient anatomy while allowing improved joint access, and is intended to be the first component of a three-element modular system offering stemless, traditional, and reverse shoulder replacement options. According to a comparative study published in the Journal of Shoulder and Elbow Surgery, the inlay glenoid design used with the system demonstrated superior biomechanical stability compared to onlay alternatives.PR NewswireHemiCAP® Inlay Arthroplasty Evolves into Mature PlatformArthrosurface, Inc. announced the publication of mid-term clinical data in the American Journal of Sports Medicine for its HemiCAP® metal resurfacing implant used to treat osteochondral talar defects after failed previous surgery. The study reported 88% patient satisfaction and a 2% revision rate with no implant loosening at the 10-year milestone. The HemiCAP platform now has over 3,000 surgeon users, more than 100,000 implantations, and over 200 peer-reviewed publications, with the company positioning this as validation of its joint preservation strategy as an alternative to total joint replacement and fusion.